That’s 11 patients recruited thus far with 26 in total needed for 2A.
They expect to update the market in regards to efficacy in Q3/24 which sounds more realistic.
- Forums
- ASX - By Stock
- Ann: Update on ACCENT Trial in Pancreatic Cancer
That’s 11 patients recruited thus far with 26 in total needed...
-
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
|
|||||
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.27M |
Open | High | Low | Value | Volume |
13.0¢ | 13.0¢ | 12.0¢ | $21.58K | 171.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 52391 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 111182 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 52391 | 0.125 |
2 | 60699 | 0.120 |
4 | 343500 | 0.115 |
2 | 33333 | 0.110 |
6 | 306762 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 111182 | 2 |
0.135 | 25000 | 1 |
0.140 | 73907 | 2 |
0.145 | 120000 | 3 |
0.150 | 62552 | 3 |
Last trade - 15.17pm 27/08/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online